A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge

Ebola virus (EBOV), isolate Makona, was the causative agent of the West African epidemic devastating predominantly Guinea, Liberia and Sierra Leone from 2013–2016. While several experimental vaccine and treatment approaches have been accelerated through human clinical trials, there is still no appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Domi, Arban, Feldmann, Friederike, Basu, Rahul, McCurley, Nathanael, Shifflett, Kyle, Emanuel, Jackson, Hellerstein, Michael S., Guirakhoo, Farshad, Orlandi, Chiara, Flinko, Robin, Lewis, George K., Hanley, Patrick W., Feldmann, Heinz, Robinson, Harriet L., Marzi, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770434/
https://www.ncbi.nlm.nih.gov/pubmed/29339750
http://dx.doi.org/10.1038/s41598-017-19041-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770434/
https://www.ncbi.nlm.nih.gov/pubmed/29339750
http://dx.doi.org/10.1038/s41598-017-19041-y

Ejemplares similares